50 million
Epilepsy is estimated to affect around 50 million people around the world, but it's estimated that if diagnosed and properly treated, up to 70% could live seizure-free lives.
30%
Around 30% of newly diagnosed patients with epilepsy don’t respond to conventional monotherapy or polytherapy treatments and continue to suffer from seizures.
86%
In a small scale British study, children with epilepsy experienced an 86% average reduction in seizure frequency when treated with whole-plant medical cannabis oil.
51%
A review of patients with treatment-resistant epilepsy found convulsive seizures decreased by 51% and total seizures fell by 48% after 12 weeks of CBD treatment.
Symptoms
‘Rising’ feeling in the tummy
Becoming stiff or rigid
Collapsing
Experiencing ‘fits’ or uncontrollable shaking/jerking
Experiencing unusual tastes or smells
Loosing awareness of surroundings
Tingling sensation in arms or legs
If you are suffering from any of these symptoms. Please speak with your GP to find out more.
Treatment options:
When a person is diagnosed with epilepsy, they are usually prescribed anti-epileptic drugs (AEDs) or anti-seizure medication (ASM) to help them manage their symptoms. In some cases, if they are not experiencing sufficient relief with these options, surgery may be considered to remove a small section of the brain, or insert an electrical device that can help control seizures.
Brivaracetam
Carbamazepine
Clobazam
Clonazepam
Lamotrigine
Levetiracetam
Whether you’re new to cannabis-based medicines, switching from another medical cannabis clinic, or self-medicating, we’ll put you back in control of your health.
Condition Peripheral Neuropathy
Subscriber 2 years
Condition Anxiety & Depression
Subscriber 2 years
Condition Depression
Subscriber 2 years
Condition Chronic Pain
Subscriber 3 years
Condition Restless Legs Syndrome
Subscriber 2 years
Condition Insomnia
Subscriber 2 years
Condition Depression
Subscriber 2 years
Condition CRPS
Subscriber 2 years
Condition Adjunctive Cancer Care
Subscriber 2 years
Condition Ehlers-Danlos Syndrome
Subscriber 2 years
Condition Insomnia & Chronic Pain
Subscriber 2 years
Condition ADHD
Subscriber 2 years
Condition Endometriosis
Subscriber 2 years
Condition Chronic Pain
Subscriber 2 years
Condition Low Back Pain
Subscriber 3 years
Condition Arthritis
Subscriber 2 years
Condition ADHD
Subscriber 2 years
Condition Anxiety & ADHD
Subscriber 2 years
Condition Chronic Pain
Subscriber 2 years
Condition Anxiety & Depression
Subscriber 2 years
Condition Chronic Pain
Subscriber 2 years
Condition Endometriosis
Subscriber 2 years
Condition PTSD
Subscriber 2 years
Condition Fibromyalgia
Subscriber 2 years
"Epilepsy involves recurrent seizures due to abnormal brain activity. Cannabidiol (CBD), a component of medicinal cannabis, has demonstrated efficacy in reducing seizure frequency in some patients, as evidenced by clinical trials, by modulating the endocannabinoid system."
Dr Sue Clenton
Medical Director
12. 07. 2023
When applied as part of a tailored and managed treatment plan, medical cannabis has been shown to improve the overall control of epileptic seizures. In fact, it is the only non-pharmaceutical treatment option that has been approved by the National Institute for Health and Care Excellence (NICE) in England for two exceedingly rare forms of epilepsy.
12. 07. 2023
10. 02. 2024
International Epilepsy Day 2026 offers a timely look at epilepsy care in the UK. With over 630,000 people affected here in the UK, this guide explains how peoplle with epilepsy can legally acces medical cannabis treatment, along with seizure management research, and how legal frameworks continue to shape treatment options.
10. 02. 2024
14. 07. 2023
Neurological disorders. Varied, potentially devastating, and hard to group into one easy-to-digest category. They are essentially diseases of the central and peripheral nervous system conditions and include epilepsy, multiple sclerosis, Parkinson’s disease, Alzheimer's disease and dementia, ALS, Bell's palsy, and a huge range of separate neuromuscular disorders.
14. 07. 2023
When medical cannabis was legalised in the UK back in November 2018, severe treatment-resistant epilepsy was one of the first conditions to be approved for cannabis-based treatments on the NHS.
This is because unfortunately, around 30% of people with epilepsy do not respond to the conventional, traditional treatment options available. But, medical cannabis, and cannabis-derived medicines, have shown promising results in managing common symptoms associated with epilepsy, especially its effects on seizure onset and frequency.
At the moment, the NHS only, and rarely, prescribe one licensed cannabis-based medicine to treat severe, treatment-resistant epilepsy. This is called Epidiolex, and is used to treat the seizures experienced by those with Lennox-Gastaut syndrome and Dravet syndrome.
However, private medical cannabis clinics like Releaf have more prescribing freedom. At Releaf, our team of expert consultants can prescribe a range of different cannabis derived treatments to patients with different types of epilepsy to best suit their needs, lifestyle, and budget.
To you have been unable to find success with conventional epilepsy treatments, medical cannabis may be an option worth considering. Find out if this approach may be appropriate for you by checking your eligibility today.
